loading
loading
Search fieldHome page Seeking Alpha - Power to InvestorsSearch for Symbols, analysts, keywordsAbout PremiumCreate free accountLog in Mirum Pharmaceuticals to report Livmarli trial results Monday Oct 11, 2026, 5:49 PM ETMirum Pharmaceuticals, Inc. (MIRM) StockBy : Rob Williams, SA News Editor Mirum Pharmaceuticals (MIRM) said it will release topline results from a late-stage clinical trial of its Livmarli treatment on Monday, October 12, providing investors with a potential catalyst as the company seeks to expand the drug's use in rare liver diseases. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our feedback forum. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. Search fieldEntering text into the input field will update the search result below Recommended For You
document fetched 2026-10-12 02:52 · canonical https://seekingalpha.com/news/4651951-mirum-pharmaceuticals-to-report-livmarli-trial-results-monday?feed_item_type=news